IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORETTI, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.555
EU - Europa 2.657
AS - Asia 2.533
SA - Sud America 494
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.492
SG - Singapore 1.293
UA - Ucraina 587
IE - Irlanda 440
BR - Brasile 374
SE - Svezia 326
CN - Cina 321
RU - Federazione Russa 313
HK - Hong Kong 294
VN - Vietnam 263
IT - Italia 249
DE - Germania 229
FI - Finlandia 149
FR - Francia 146
KR - Corea 73
IN - India 72
GB - Regno Unito 71
BD - Bangladesh 44
AR - Argentina 40
TR - Turchia 28
MX - Messico 25
PL - Polonia 25
CO - Colombia 24
ZA - Sudafrica 24
CZ - Repubblica Ceca 22
CA - Canada 21
IQ - Iraq 20
EC - Ecuador 19
CH - Svizzera 16
NL - Olanda 15
BE - Belgio 14
JP - Giappone 14
PK - Pakistan 14
AT - Austria 13
UZ - Uzbekistan 13
ES - Italia 12
GR - Grecia 12
CI - Costa d'Avorio 10
PH - Filippine 10
SA - Arabia Saudita 10
LB - Libano 9
CL - Cile 8
ID - Indonesia 8
KE - Kenya 8
PE - Perù 8
VE - Venezuela 8
AZ - Azerbaigian 7
JO - Giordania 7
TN - Tunisia 7
EG - Egitto 6
BO - Bolivia 5
IL - Israele 5
MA - Marocco 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
LT - Lituania 4
MY - Malesia 4
PS - Palestinian Territory 4
EU - Europa 3
JM - Giamaica 3
KZ - Kazakistan 3
PA - Panama 3
RS - Serbia 3
UY - Uruguay 3
AU - Australia 2
CR - Costa Rica 2
LC - Santa Lucia 2
LK - Sri Lanka 2
LR - Liberia 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LV - Lettonia 1
ML - Mali 1
MW - Malawi 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
QA - Qatar 1
Totale 9.315
Salva come PNG Salva come JPEG
Città #
Singapore 918
Chandler 494
Dublin 440
Hong Kong 290
San Mateo 271
Jacksonville 251
San Jose 217
Boardman 165
Ashburn 140
Santa Clara 138
Dong Ket 116
Altamura 114
Medford 108
Princeton 108
Des Moines 103
Moscow 95
Lauterbourg 92
Wilmington 92
Lawrence 86
Beijing 79
Ann Arbor 72
Perugia 69
Seoul 69
Munich 67
Andover 62
Ho Chi Minh City 50
Falls Church 47
New York 43
São Paulo 41
The Dalles 38
Los Angeles 36
Saint Petersburg 36
Hanoi 34
Turku 28
Norwalk 27
Dearborn 25
Piscataway 25
Woodbridge 23
Chennai 19
Frankfurt am Main 19
Orem 19
San Paolo di Civitate 19
Brooklyn 17
Dallas 17
Warsaw 15
Brussels 14
Johannesburg 14
Brno 13
Helsinki 13
Shanghai 13
Nuremberg 12
Tokyo 12
Chicago 11
Abidjan 10
Haiphong 10
Milan 10
Baghdad 9
Boston 9
Fremont 9
Mumbai 9
Columbus 8
Denver 8
Houston 8
London 8
Medellín 8
Mexico City 8
Nairobi 8
Rio de Janeiro 8
Atlanta 7
Cambridge 7
Fortaleza 7
Guayaquil 7
Izmir 7
Manchester 7
Amman 6
Ankara 6
Den Haag 6
Jinan 6
Montreal 6
Nagpur 6
Olomouc 6
Phoenix 6
Poplar 6
Toronto 6
Amsterdam 5
Auburn Hills 5
Baku 5
Belo Horizonte 5
Brasília 5
Cape Town 5
Charlotte 5
Falkenstein 5
Goiânia 5
Hefei 5
Jeddah 5
Lausanne 5
Nanjing 5
Riyadh 5
San Diego 5
Santiago 5
Totale 5.648
Salva come PNG Salva come JPEG
Nome #
Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. 162
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 146
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 146
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 144
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 139
T cell apoptosis by kynurenines. 137
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 130
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 129
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 125
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 122
3H-aniracetam binds to specific recognition sites in brain membranes 121
Dual effect of IL-4 on resistance to systemic gram-negative infection and production on TNF-alfa 120
Antilymphoma graft responses in the mouse brain: a study of T-dependent functions. 117
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 117
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 116
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 116
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 116
Antigenic changes related to drug action. 114
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 112
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 111
Antitumor activity of three nitrosourea analogues in different experimental tumor system 111
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 110
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. 110
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 110
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 107
Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. 107
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 105
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 102
Modulation of tryptophan catabolism by regulatory T cells 101
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 100
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease 100
[In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC]. 99
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 98
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 97
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 96
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 96
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 96
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 95
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia. 95
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 93
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 93
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 93
CTLA-4-Ig regulates tryptophan catabolism in vivo. 92
T cell apoptosis by tryptophan catabolism 92
Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens. 92
IL-9 protects mice from Fram-negative bacterial shock: suppression of alfa-TNF, IL-12 and gamma-IFN, and induction of IL-10. 91
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 90
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 89
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 88
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 87
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 87
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 85
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 85
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 85
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 84
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 84
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 83
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 83
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. 83
Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. 82
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 81
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 81
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 80
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 79
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 79
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 79
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 77
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 77
Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotides. 77
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 77
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 77
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 76
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 74
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 74
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 74
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives. 73
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 73
Chemical xenogenization of tumor cells. 72
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 72
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 71
Rational bases of cancer immunochemotherapy: drug effects on antigen expression 71
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 70
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies. 70
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. 69
Cytokines and tumours: problems and perspectives. 69
Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. 69
Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative. 69
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 69
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 68
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 65
Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo. 63
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 60
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens. 60
Regulation of tumor antigen expression by drugs acting as mutagens and/or gene activators. 60
Molecular and genomic aspects of xenogenizing-alkylating drugs. 60
I Chemioterapici 59
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 58
Tryptophan catabolism in nonobese diabetic mice. 58
Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone 56
Totale 9.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021245 0 0 0 0 0 0 0 0 0 30 84 131
2021/2022961 15 168 9 56 73 27 16 302 18 29 74 174
2022/20231.664 128 295 15 124 145 247 1 87 556 5 47 14
2023/2024509 44 88 19 6 3 2 108 7 65 8 71 88
2024/20251.357 21 125 77 42 195 61 11 81 265 91 252 136
2025/20262.995 197 258 166 403 354 272 557 213 320 255 0 0
Totale 9.507